Metastatic Breast Cancer

STA Pharma completes clinical supply of PhoenixMD’s breast cancer treatment

10-Jun-2019 By Maggie Lynch

Clinical trial supply for the first targeted treatment of triple-negative breast cancer completed through PhoenixMD and STA Pharmaceutical agreement.

US FDA approves Pfizer’s PARP inhibitor for metastatic breast cancer

23-Oct-2018 By Maggie Lynch

The FDA approved Pfizer’s therapy for metastatic breast cancers, after clinical trials showed strong progression-free survival rates.

ASCO 2016

Social media speeds study recruitment for cancer researchers

07-Jun-2016 By Melissa Fassbender

Researchers used pre-existing platforms to identify and recruit patients for a cancer research study – connecting advocacy groups, social media, and a dedicated website to register patients.

Bavarian Nordic enter breast cancer vaccine clinical trials

10-Jan-2007 By Dr Matt Wilkinson

BN ImmunoTherapeutics, the US subsidiary of Denmark's Bavarian
Nordic, has started clinical trials of MVA-BN-HER2, a new vaccine
targeting breast cancer.

Breast cancer therapeutics benefits from cytotoxic alternatives

22-Dec-2005 By Wai Lang Chu

The breast cancer therapeutics market is expected to show sustained
growth and opportunity for new market participants as greater
efficacy and reduced toxicity of innovative breast cancer therapies
increase their uptake.

Study shows R&D drug efforts for breast cancer

03-Nov-2005 By Wai Lang Chu

According to a new report, more than 400 new medicines are in
development to treat diseases that affect US women, including 62
medicines now in testing to treat breast cancer.